Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis

Abstract

Objectives. This study assessed the impact of cardiac risk assessment using gated singlephoton emission computed tomography (SPECT) on cardiac events in end-stage renal disease (ESRD) patients. Methods. We evaluated 215 asymptomatic patients who began dialysis between January 2005 and April 2009. Baseline electrocardiography and echocardiography were performed in all the patients. The subjects were stratified into low-and high-risk groups according to the baseline cardiac status, and gated SPECT was additionally recommended for the high-risk patients. Results. The study population consisted of 50 low-and 165 high-risk patients undergoing SPECT. Among the high-risk patients, 75 (45.5%) showed perfusion defects on SPECT and their overall cardiac-event rate per person-year of follow-up was 15.0%, significantly higher than 4.5% in high-risk group without perfusion defect and 1.2% in low-risk group. The presence of perfusion defect was a significant independent predictor of adverse cardiac events [hazard ratio (HR) 2.11; 95% confidence interval (CI) 1.05-4.24; P =.035]. When gated SPECT was added to the clinical and the echocardiographic variables, the prognostic stratification significantly improved (P >.001). However, coronary revascularization was not associated with improved cardiac event-free survival (HR 0.62; 95% CI 0.26-1.52; P =.296). Conclusions. Gated SPECT may provide additional prognostic information for cardiac risk stratification, particularly among high-risk patients starting dialysis. Copyright © 2012 American Society of Nuclear Cardiology.